Day: June 29, 2022

SAN FRANCISCO, June 29, 2022 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the pricing of its previously announced underwritten public offering of 18,675,466 shares of its common stock and accompanying warrants to purchase up to 9,337,733 shares of common stock at a combined public offering price of $3.55 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,944,252 shares of its common stock and accompanying warrants to purchase up to 3,972,126 shares of common stock at a combined public offering price of $3.549. The pre-funded warrants have an exercise price of $0.001 per share, and are exercisable...

BROSSARD, Québec, June 29, 2022 (GLOBE NEWSWIRE) — CHARBONE HYDROGEN Corporation (TSXV:CH) (“CHARBONE”) is pleased to announce an important milestone with the signature , of a non-binding Letter of Intent (the “LOI”) with ELOGEN SAS (“ELOGEN”) a GTT Company, pursuant to which CHARBONE will be securing its supply chain of PEM electrolysers (Proton Exchange Membrane) for up to 100 Megawatts over a period of four (4) years from 2023 to 2026 under a definitive multi-year master supply agreement (the “Agreement”) to be negotiated by the parties on/or before November 30, 2022. The PEM electrolysers to be supplied by ELOGEN to CHARBONE will be comprised of a mix of the full range of products offered by ELOGEN, including 0,5 MW, 1,0 MW and the 5,0 MW for all CHARBONE North American green hydrogen projects. Under the Agreement, the parties...

The BenchMark ULTRA PLUS tissue staining system, with optimised workflow, testing efficiency and environmentally sustainable features, enables pathologists to provide high-quality, time-critical results to doctors and patients. With laboratory diagnostics involved in more than two-thirds of healthcare decision making, innovative laboratory solutions that enable an accurate and timely diagnosis are crucial to successful treatment. About 17 million new cases of cancer are diagnosed worldwide each year, and nearly 10 million people die from the disease.1Basel, 29 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the BenchMark ULTRA PLUS system, its newest advanced tissue staining platform. The system enables quick and accurate test results so clinicians can make timely decisions regarding a patient’s care...

Regulated Information Nyrstar NV – Results of the annual general shareholders’ meetings held on 28 June 2022 29 June 2021 at 07.00 CEST Nyrstar NV (the “Company”) held its annual general shareholders’ meeting (“AGM”) in Brussels today. The AGM did not have an attendance quorum requirement for the items on the agenda. The shareholders approved all items on the agenda of the AGM. About NyrstarThe Company is incorporated in Belgium and, following completion of the recapitalisation/restructuring has a 2% shareholding in the Nyrstar group. The Company is listed on Euronext Brussels under the symbol NYR. For further information please visit the Nyrstar website: www.nyrstar.be For further information contact: Anthony Simms –        Head of External Affairs and Legal      M: +41 79 722 2152  anthony.simms@nyrstar.com...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces that the clinical module of its rolling new drug application (NDA) for vamorolone in Duchenne muscular dystrophy (DMD) has been submitted to the U.S. Food and Drug Administration (FDA). Finalization of the NDA submission to start the FDA official review is postponed by 4-6 months to Q4-2022 after a third-party contract manufacturing organization (CMO) communicated a delay in establishing FDA-inspection readiness. Santhera commenced the NDA filing as a rolling submission in March 2022 following a successful pre-NDA meeting with the FDA. In its conclusions from this meeting, the FDA considered the proposed clinical efficacy and safety data sufficient to support an NDA filing of vamorolone for the treatment of DMD....

ESG INDUSTRY 50 Top Rated_2022 IMCD 2022 ESG Industry Top PerformerROTTERDAM, The Netherlands (29 June 2022) – IMCD N.V., (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, was recognised by Sustainalytics as an ESG Industry Top Rated Company. With a score of 13.8 (low risk) IMCD ranks first (lowest risk) among over 180 international peers in trading and distribution. It places the company in the top seven percent of almost 15,000 companies assessed worldwide. Sustainalytics, a Morningstar company, is a globally recognised provider of ESG research, ratings and data that supports investors around the world with the development and implementation of responsible investment strategies. Its ESG Risk Ratings measure a company’s exposure to industry-specific material ESG risks and how well a company...

SIKA EXPANDS PRODUCTION OF CONCRETE ADMIXTURES IN THE USA Sika is bringing a new manufacturing plant for concrete admixtures on stream in Stafford, Virginia. With the opening of the plant near Washington D.C., Sika is increasing its production capacity in the important American construction market so that it can readily satisfy the strong demand in the Northeast and Mid-Atlantic regions. With over 75 million inhabitants, the urban centers in the Northeast, like New York, Philadelphia, or Boston, are very densely populated and account for more than 25% of US economic output. The new plant is well positioned to support the additional needs of the announced infrastructure program of CHF 200-250 billion in the aforementioned two regions. Sika has been benefiting from the strong demand in the construction sector over recent years. The new facility...

WISeKey’s WISe.ART NFT Marketplace adds collection of NFTs from new artists WISeKey releases new version of WISe.ART NFT Marketplace with trusted NFTs from new artists WISe.ART is working on cross-blockchain support, enabling a truly open data economy with the support of Ethereum, Polygon and CasperLabs and gradually adding new chains to ensure interoperability and scalability as part of its overall strategy to act as a leading platform of the Web3.0 revolution WISe.Art platform is developing into a fully-fledged marketplace with its own digital currency, the ability to include curators and multipliers, white-labeling options and custom-made NFT designGeneva – June 29, 2022 – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI and IoT company, announced today...

OSLO, Norway (29 June 2022) – TGS ASA (“TGS”, OSE: TGS) and Magseis Fairfield ASA (“Magseis”, OSE: MSEIS) announce today that they have entered into a transaction agreement (the “Transaction Agreement“) whereby TGS on and subject to certain terms and conditions will put forward a voluntary exchange offer (the “Offer”) to acquire all shares of Magseis for a consideration to the Magseis shareholders in the form of 0.0426 ordinary shares of TGS and NOK 2.30 in cash per Magseis share (the “Offer Consideration”). Based on the closing price of TGS on 28 June 2022, the value of the Offer Consideration is equal to NOK 8.6048 per Magseis share, and the Offer values the total issued share capital of Magseis at approximately NOK 2,333 million. The board of directors of Magseis (the “Board“) has unanimously resolved...

SHANGHAI, China, June 29, 2022 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today issued the following statement in response to allegations made in a report by Grizzly Research LLC, a short seller. The report is without merit and contains numerous errors, unsupported speculations and misleading conclusions and interpretations regarding information relating to the Company. The Company’s board of directors, including the audit committee, is reviewing the allegations and considering the appropriate course of action to protect the interests of all shareholders. The Company will make additional disclosures in due course consistent with the requirements of applicable rules and regulations of the Securities and...